{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:28:56Z","timestamp":1790706536093,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2022-YGJC-61;2022-MS-219"],"award-info":[{"award-number":["2022-YGJC-61;2022-MS-219"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"345 Talent Project of the Shengjing Hospital of China Medical University and Applied Basic Research Program of Liaoning Provincial Department of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57966-5","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T17:21:39Z","timestamp":1742836899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-6855","authenticated-orcid":false,"given":"Hiroshi","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1141-5263","authenticated-orcid":false,"given":"Huihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"57966_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"57966_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar, S. V. Multiple myeloma: every year a new standard? Hematol. Oncol. 37, 62\u201365 (2019).","journal-title":"Hematol. Oncol."},{"key":"57966_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.blre.2018.11.003","volume":"34","author":"D Vr\u00e1bel","year":"2019","unstructured":"Vr\u00e1bel, D., Pour, L. & \u0160ev\u010d\u00edkov\u00e1, S. The impact of NF-\u03baB signaling on pathogenesis and current treatment strategies in multiple myeloma. Blood Rev. 34, 56\u201366 (2019).","journal-title":"Blood Rev."},{"key":"57966_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00854-5","volume":"8","author":"X Jian","year":"2020","unstructured":"Jian, X. et al. Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria. Microbiome 8, 74 (2020).","journal-title":"Microbiome"},{"key":"57966_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","volume":"133","author":"C Pawlyn","year":"2019","unstructured":"Pawlyn, C. & Davies, F. E. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood 133, 660\u2013675 (2019).","journal-title":"Blood"},{"key":"57966_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","volume":"60","author":"LD Fricker","year":"2020","unstructured":"Fricker, L. D. Proteasome inhibitor drugs. Annu. Rev. Pharmacol. Toxicol. 60, 457\u2013476 (2020).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"57966_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani, F. R. et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69, 107\u2013120 (2019).","journal-title":"Hepatology"},{"key":"57966_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1058272","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Xiang, Y., Li, Y. & Zhang, J. Gut microbiome in multiple myeloma: mechanisms of progression and clinical applications. Front. Immunol. 13, 1058272 (2022).","journal-title":"Front. Immunol."},{"key":"57966_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.21147\/j.issn.1000-9604.2023.03.05","volume":"35","author":"B Pei","year":"2023","unstructured":"Pei, B., Ma, X., Wu, N., Wang, C. & Yang, W. Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors. Chin. J. Cancer Res. 35, 252\u2013265 (2023).","journal-title":"Chin. J. Cancer Res."},{"key":"57966_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07305-8","volume":"9","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto, A. et al. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nat. Commun. 9, 4832 (2018).","journal-title":"Nat. Commun."},{"key":"57966_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.725284","volume":"11","author":"F Zhao","year":"2021","unstructured":"Zhao, F., An, R., Wang, L., Shan, J. & Wang, X. Specific gut microbiome and serum metabolome changes in lung cancer patients. Front. Cell Infect. Microbiol. 11, 725284 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"57966_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.ade0522","volume":"381","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9. Science 381, 851\u2013857 (2023).","journal-title":"Science"},{"key":"57966_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.768606","volume":"13","author":"RF Saito","year":"2022","unstructured":"Saito, R. F., Andrade, L. N. S., Bustos, S. O. & Chammas, R. Phosphatidylcholine-derived lipid mediators: the crosstalk between cancer cells and immune cells. Front. Immunol. 13, 768606 (2022).","journal-title":"Front. Immunol."},{"key":"57966_CR14","doi-asserted-by":"crossref","unstructured":"Law S. H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 20, 1149 (2019).","DOI":"10.3390\/ijms20051149"},{"key":"57966_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3389\/fimmu.2019.01159","volume":"10","author":"D Mathew","year":"2019","unstructured":"Mathew, D. et al. LPA(5) is an inhibitory receptor that suppresses CD8 T-cell cytotoxic function via disruption of early TCR signaling. Front. Immunol. 10, 1159 (2019).","journal-title":"Front. Immunol."},{"key":"57966_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110013","volume":"37","author":"E Matas-Rico","year":"2021","unstructured":"Matas-Rico, E. et al. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells. Cell Rep. 37, 110013 (2021).","journal-title":"Cell Rep."},{"key":"57966_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41562-6","volume":"14","author":"C Botta","year":"2023","unstructured":"Botta, C. et al. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nat. Commun. 14, 5825 (2023).","journal-title":"Nat. Commun."},{"key":"57966_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"57966_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat. Med. 27, 820\u2013832 (2021).","journal-title":"Nat. Med."},{"key":"57966_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121723","volume":"288","author":"R Han","year":"2022","unstructured":"Han, R. et al. Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategy. Biomaterials 288, 121723 (2022).","journal-title":"Biomaterials"},{"key":"57966_CR21","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.cell.2020.10.045","volume":"183","author":"L Jiang","year":"2020","unstructured":"Jiang, L. et al. Direct tumor killing and immunotherapy through anti-SerpinB9 therapy. Cell 183, 1219\u20131233.e1218 (2020).","journal-title":"Cell"},{"key":"57966_CR22","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1021\/acs.jproteome.1c00007","volume":"20","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Proteomics-based approach reveals the involvement of SERPINB9 in recurrent and relapsed multiple myeloma. J. Proteome Res. 20, 2673\u20132686 (2021).","journal-title":"J. Proteome Res."},{"key":"57966_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10863-020-09846-4","volume":"52","author":"W Szlasa","year":"2020","unstructured":"Szlasa, W., Zendran, I., Zalesi\u0144ska, A., Tarek, M. & Kulbacka, J. Lipid composition of the cancer cell membrane. J. Bioenerg. Biomembr. 52, 321\u2013342 (2020).","journal-title":"J. Bioenerg. Biomembr."},{"key":"57966_CR24","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1158\/1541-7786.MCR-11-0245","volume":"9","author":"W Jia","year":"2011","unstructured":"Jia, W., Eneh, J. O., Ratnaparkhe, S., Altman, M. K. & Murph, M. M. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. Mol. Cancer Res. 9, 1732\u20131745 (2011).","journal-title":"Mol. Cancer Res."},{"key":"57966_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948115","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP-1. EMBO Rep. 20, e48115 (2019).","journal-title":"EMBO Rep."},{"key":"57966_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/leu.2016.296","volume":"31","author":"S Manier","year":"2017","unstructured":"Manier, S. et al. The LIN28B\/let-7 axis is a novel therapeutic pathway in multiple myeloma. Leukemia 31, 853\u2013860 (2017).","journal-title":"Leukemia"},{"key":"57966_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molcel.2012.08.004","volume":"48","author":"ML Wilbert","year":"2012","unstructured":"Wilbert, M. L. et al. LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol. Cell 48, 195\u2013206 (2012).","journal-title":"Mol. Cell"},{"key":"57966_CR28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood.2021014749","volume":"140","author":"E Menu","year":"2022","unstructured":"Menu, E. & Vanderkerken, K. Exosomes in multiple myeloma: from bench to bedside. Blood 140, 2429\u20132442 (2022).","journal-title":"Blood"},{"key":"57966_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2478\/jtim-2023-0124","volume":"11","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Exosomes and their derivatives as biomarkers and therapeutic delivery agents for cardiovascular diseases: situations and challenges. J. Transl. Int. Med. 11, 341\u2013354 (2023).","journal-title":"J. Transl. Int. Med."},{"key":"57966_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1102471","volume":"13","author":"C Giannotta","year":"2022","unstructured":"Giannotta, C., Autino, F. & Massaia, M. The immune suppressive tumor microenvironment in multiple myeloma: the contribution of myeloid-derived suppressor cells. Front. Immunol. 13, 1102471 (2022).","journal-title":"Front. Immunol."},{"key":"57966_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fonc.2018.00665","volume":"8","author":"KK Jovanovi\u0107","year":"2018","unstructured":"Jovanovi\u0107, K. K. et al. Deregulation and targeting of TP53 pathway in multiple myeloma. Front. Oncol. 8, 665 (2018).","journal-title":"Front. Oncol."},{"key":"57966_CR32","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41556-020-0559-z","volume":"22","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. Nat. Cell Biol. 22, 1056\u20131063 (2020).","journal-title":"Nat. Cell Biol."},{"key":"57966_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.chom.2023.01.013","volume":"31","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance. Cell Host Microbe 31, 418\u2013432.e418 (2023).","journal-title":"Cell Host Microbe"},{"key":"57966_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41388-022-02569-3","volume":"42","author":"F Shi","year":"2023","unstructured":"Shi, F. et al. Altered gut microbiome composition by appendectomy contributes to colorectal cancer. Oncogene 42, 530\u2013540 (2023).","journal-title":"Oncogene"},{"key":"57966_CR35","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","volume":"67","author":"B Flemer","year":"2018","unstructured":"Flemer, B. et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 67, 1454\u20131463 (2018).","journal-title":"Gut"},{"key":"57966_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/2326-6066.CIR-19-1014","volume":"8","author":"Z Peng","year":"2020","unstructured":"Peng, Z. et al. The gut microbiome is associated with clinical response to anti-PD-1\/PD-L1 immunotherapy in gastrointestinal cancer. Cancer Immunol. Res. 8, 1251\u20131261 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"57966_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"P Guevara-Ram\u00edrez","year":"2023","unstructured":"Guevara-Ram\u00edrez, P. et al. Role of the gut microbiota in hematologic cancer. Front. Microbiol. 14, 1185787 (2023).","journal-title":"Front. Microbiol."},{"key":"57966_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113591","volume":"43","author":"CJ Yang","year":"2024","unstructured":"Yang, C. J. et al. Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury. Cell Rep. 43, 113591 (2024).","journal-title":"Cell Rep."},{"key":"57966_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1042\/bj3620097","volume":"362","author":"M Houweling","year":"2002","unstructured":"Houweling, M., Klein, W. & Geelen, M. J. Regulation of phosphatidylcholine and phosphatidylethanolamine synthesis in rat hepatocytes by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem. J. 362, 97\u2013104 (2002).","journal-title":"Biochem. J."},{"key":"57966_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118077","volume":"260","author":"Y Zhong","year":"2020","unstructured":"Zhong, Y. et al. FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells. Life Sci. 260, 118077 (2020).","journal-title":"Life Sci."},{"key":"57966_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","volume":"71","author":"M Podhorecka","year":"2017","unstructured":"Podhorecka, M., Ibanez, B. & Dmoszy\u0144ska, A. Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig. Med. Dosw. 71, 170\u2013175 (2017).","journal-title":"Postepy Hig. Med. Dosw."},{"key":"57966_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ncb3453","volume":"19","author":"KM Tsanov","year":"2017","unstructured":"Tsanov, K. M. et al. LIN28 phosphorylation by MAPK\/ERK couples signalling to the post-transcriptional control of pluripotency. Nat. Cell Biol. 19, 60\u201367 (2017).","journal-title":"Nat. Cell Biol."},{"key":"57966_CR43","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1086\/497606","volume":"192","author":"AT Rowshani","year":"2005","unstructured":"Rowshani, A. T. et al. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J. Infect. Dis. 192, 1908\u20131911 (2005).","journal-title":"J. Infect. Dis."},{"key":"57966_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J. Exp. Clin. Cancer Res. 40, 206 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"57966_CR45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41419-023-05877-y","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma. Cell Death Dis. 14, 350 (2023).","journal-title":"Cell Death Dis."},{"key":"57966_CR46","doi-asserted-by":"crossref","unstructured":"Mao M. et al. Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer. J. Immunother. Cancer 10, e005668 (2022).","DOI":"10.1136\/jitc-2022-005668"},{"key":"57966_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-024-02972-6","volume":"43","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis. J. Exp. Clin. Cancer Res. 43, 68 (2024).","journal-title":"J. Exp. Clin. Cancer Res."}],"updated-by":[{"DOI":"10.1038\/s41467-025-67875-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57966-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:03:05Z","timestamp":1769518985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57966-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57966"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57966-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-025-67875-2","URL":"https:\/\/doi.org\/10.1038\/s41467-025-67875-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2863"}}